Clinical Trial: Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase IV, Multicentre, Open-Label, Single Group Study to Evaluate the Dosing, Efficacy and Safety of Lanreotide Autogel in Patients With Acromegaly Previously Treated Wi

Brief Summary: The purpose of this study is to assess the efficacy, safety and patient acceptability of Somatuline Autogel in patients with acromegaly previously treated with octreotide LAR.